Related Experiment Video
Updated: Jun 18, 2026
05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
The Reference Guide to Integrate Smart Insulin Pens Into Data-Driven Diabetes Care and Education Services.
Hope Warshaw1, Diana Isaacs2, Janice MacLeod3
1Hope Warshaw Associates, LLC, Asheville, North Carolina.
The Diabetes Educator
|August 12, 2020
Summary
Smart insulin pens offer a new way for people with diabetes to manage their insulin therapy. These devices simplify dose recording and data sharing, improving diabetes management for patients and clinicians.
Area of Science:
- Diabetes Management
- Medical Device Technology
Background:
- Over 7 million Americans with diabetes rely on insulin therapy.
- Traditional insulin delivery methods (syringes, vials, pens) present significant challenges for patients and healthcare providers.
- Accurate insulin dosing and data tracking are crucial for effective diabetes self-management.
Purpose of the Study:
- Introduce smart insulin pens, a new category of integrated insulin delivery systems.
- Highlight how smart pens address challenges in rapid-acting insulin dosing.
- Discuss the role of smart pens in facilitating data-driven diabetes care.
Main Methods:
- Review of smart insulin pen technology and integrated management systems.
- Analysis of features enabling easier and more accurate insulin dose recording and calculation.
- Examination of data sharing capabilities between patients and clinicians.
Main Results:
- Smart insulin pens streamline the insulin injection process.
- Enhanced accuracy in dose recording and calculation is achievable with smart pens.
- Improved data sharing facilitates better communication and analysis between patients and clinicians.
Conclusions:
- Smart insulin pens simplify insulin injection therapy, minimizing associated complexities.
- These devices provide comprehensive, integrated data for efficient analysis and reporting.
- Smart pens represent a key digital tool for optimizing data-driven diabetes care.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...